Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C.
暂无分享,去创建一个
[1] N. Kabbaj,et al. Thyroid disorders during interferon alpha therapy in 625 patients with chronic hepatitis C: a prospective cohort study. , 2006, Annales d'endocrinologie.
[2] Y. Tomer,et al. The clinical and physiological spectrum of interferon‐alpha induced thyroiditis: Toward a new classification , 2006, Hepatology.
[3] Jacques Young,et al. Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease. , 2006, European journal of endocrinology.
[4] Sheng-Nan Lu,et al. Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: Incidence, associated factors and prognosis , 2006, Journal of gastroenterology and hepatology.
[5] O. Bouché,et al. Risk factors and long-term course of thyroid dysfunction during antiviral treatments in 221 patients with chronic hepatitis C. , 2005, Gastroenterologie clinique et biologique.
[6] C. Carella,et al. Interferon-α-Related Thyroid Disease: Pathophysiological, Epidemiological, and Clinical Aspects , 2004 .
[7] Dieter Häussinger,et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.
[8] E. Haug,et al. Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy , 2002, Journal of internal medicine.
[9] Kenneth Koury,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[10] M. Rotondi,et al. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. , 2001, The Journal of clinical endocrinology and metabolism.
[11] L. Y. Wang,et al. Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C. , 2000, European journal of endocrinology.
[12] C. Broussolle,et al. Infection par le virus de l'hépatite C et pathologies thyroïdiennes , 1999 .
[13] J. Salmerón,et al. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. , 1998, Archives of internal medicine.
[14] A. Horsch,et al. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy , 1997, Hepatology.
[15] L. Braverman,et al. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. , 1996, The American journal of medicine.
[16] P. Bedossa,et al. An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.
[17] M. Marazuela,et al. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon‐α therapy , 1996, Clinical endocrinology.
[18] M. Colombo,et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. , 1995, European journal of endocrinology.
[19] P. Guillausseau,et al. [Dysthyroidism in patients treated with interferon alpha]. , 1994, Presse medicale.
[20] C. Carella,et al. Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. , 2004, The Journal of clinical endocrinology and metabolism.
[21] F. Zoulim,et al. [Hepatitis C virus infection and thyroid diseases]. , 1999, La Revue de medecine interne.
[22] P. Marcellin,et al. Incidence of dysthyroidism during interferon therapy in chronic hepatitis C. , 1997, Hormone research.
[23] P. Marcellin,et al. [Natural history of dysthyroidism during interferon treatment of chronic hepatitis C]. , 1996, Annales d'endocrinologie.